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Introduction
Neuronal dense-core vesicles (DCVs) contain neuropeptides, 
neurotrophic factors, monoamines, and other modulatory sub-
stances that are essential during brain development and regulate 
synaptic plasticity in the adult brain (McAllister et al., 1999; 
Huang and Reichardt, 2001; Poo, 2001; Samson and Medcalf, 
2006). To date, >50 biologically active peptides have been identi-
fied that have profound effects on brain and body function. Not 
surprisingly, dysregulation of DCV signaling is associated with 
many diseases, such as mood and cognitive disorders, obe-
sity, and diabetes (Meyer-Lindenberg et al., 2011). DCVs are 
filled with cargo at the Golgi network (Kim et al., 2006) and 
transported through axons and dendrites via microtubule-based 
motors of the kinesin and dynein families (Hirokawa et al., 2009; 
Schlager and Hoogenraad, 2009). Calcium influx triggers DCV 
release from synaptic and extrasynaptic regions on axons and 
dendrites (Hartmann et al., 2001; Ludwig and Leng, 2006; 
de Wit et al., 2009b; Matsuda et al., 2009; Knobloch et al., 2012), 
and previous work identified several stimulation paradigms 
that trigger DCV fusion (Bartfai et al., 1988; Verhage et al., 
1991; Hartmann et al., 2001; Matsuda et al., 2009). Yet, little is 
known about the molecules that control the location and kinet-
ics of DCV secretion in mammalian neurons.
In contrast to the relative lack of understanding of 
DCV fusion, synaptic vesicle (SV) fusion mechanisms are 
much better understood (Jahn and Scheller, 2006; Südhof and 
Rothman, 2009). SVs cluster at active zones, fuse upon calcium 
influx, and locally recycle at the presynaptic terminal (Südhof, 
2004). DCVs are generally more dynamic (de Wit et al., 2006; 
Shakiryanova et al., 2006; Matsuda et al., 2009) and are present 
in synaptic terminals as well as neurites and perikarya, but it 
is not clear whether DCVs specifically cluster at synaptic 
terminals or use activity-dependent recruitment mechanisms 
as seen in Drosophila melanogaster neuromuscular junctions 
(Shakiryanova et al., 2006; Wong et al., 2012). Hence, transport 
and release characteristics of SVs and DCVs differ to some ex-
tent, but they also share properties such as the requirement for 
functional SNARE complexes and calcium influx to initiate fu-
sion (Xu and Xu, 2008). Therefore, proteins that function in SV 
release (Garner et al., 2000; Rosenmund et al., 2003; Verhage 
and Toonen, 2007; de Wit et al., 2009a; Sørensen, 2009) may 
have similar functions in DCV release in neurons. Yet, no can-
didates have been investigated to date.
Neuronal dense-core vesicles (DCVs) contain di-verse cargo crucial for brain development and function, but the mechanisms that control their 
release are largely unknown. We quantified activity-
dependent DCV release in hippocampal neurons at single 
vesicle resolution. DCVs fused preferentially at synaptic 
terminals. DCVs also fused at extrasynaptic sites but 
only after prolonged stimulation. In munc13-1/2–null 
mutant neurons, synaptic DCV release was reduced but 
not abolished, and synaptic preference was lost. The 
remaining fusion required prolonged stimulation, simi-
lar to extrasynaptic fusion in wild-type neurons. Con-
versely, Munc13-1 overexpression (M13OE) promoted 
extrasynaptic DCV release, also without prolonged stim-
ulation. Thus, Munc13-1/2 facilitate DCV fusion but, 
unlike for synaptic vesicles, are not essential for DCV 
release, and M13OE is sufficient to produce efficient 
DCV release extrasynaptically.
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priming proteins that are essential for SV release (Augustin 
et al., 1999; Rhee et al., 2002; Varoqueaux et al., 2002; Basu 
et al., 2007). We show that deletion of Munc13-1/2 strongly 
decreased but did not abolish DCV release, whereas Munc13-1 
overexpression (M13OE) resulted in increased DCV release. 
Strikingly, both the absence and overexpression of Munc13 
changed the synaptic preference of DCV release: Munc13 dele-
tion specifically reduced synaptic release events, whereas over-
expression increased release only from extrasynaptic sites. Thus, 
in addition to its fusion-promoting role, Munc13 also affects 
the localization of DCV release, and Munc13 overexpression 
is sufficient to promote efficient DCV release at extrasynaptic 
sites along the plasma membrane.
Results and discussion
Optical sensor for DCV release in neurons
To study neuronal DCV release, we used reporters generated by 
fusing the canonical DCV cargo proteins Neuropeptide Y (NPY) 
or Semaphorin-3a to pH-sensitive EGFP (pHluorin; Fig. 1 A 
and Fig. S1). We have previously shown that these cargo, when 
overexpressed in mouse hippocampal neurons, are coexpressed 
in the majority of DCVs with an almost 90% overlap with en-
dogenous DCV cargo Chromogranin A (de Wit et al., 2009b; 
Fig. 1 B). DCV-pHluorin release events become visible as bright 
diffraction limited spots (Fig. 1 C). To test whether these spots 
represent single or multiple DCV release events, the fluores-
cence intensity increase (F) of individual release events was 
compared with the F of DCV puncta upon NH4+ superfusion 
(to dequench intravesicular pHluorin; Fig. 1 D). The F inten-
sity plot upon NH4+ application showed a skewed distribution 
with a major population at ±6 arbitrary units (a.u.) that over-
lapped with the F of individual release events, suggesting that 
the latter are generally single vesicle fusion events (Fig. 1 D).
To initiate release of DCVs, neurons were stimulated with 
16 bursts of 50 action potentials (APs) at 50 Hz. This stimulus 
is optimal for release of the neuropeptide brain-derived neu-
rotrophic factor from hippocampal neurons (Hartmann et al., 
2001). DCV release was strongly coupled to this stimulation 
and resulting calcium influx (Fig. 1 E and Fig. S1). Only a few 
DCVs were released before or after the stimulus train (Fig. 1, 
E and F; and Fig. S1). Other stimulation paradigms were not as 
effective in releasing DCVs (Fig. S1).
DCVs do not accumulate at synapses, but 
DCV release is enriched and more efficient 
at these sites
Many proteins involved in SV fusion are enriched in synaptic 
terminals (Südhof, 2004). If these proteins were also involved 
in DCV release, DCV release should be enriched at synaptic 
sites. To test this, we quantified synaptic and extrasynap-
tic release (Fig. 2, A and B) using the SV protein synapsin 
to visualize synapses in living neurons (Gitler et al., 2004). 
Synapsin-mCherry fusion proteins formed discrete puncta 
along the dendrite that colocalized with endogenous VAMP2, 
confirming that synapsin-mCherry is correctly localized to syn-
apses (our previous results [de Wit et al., 2006]; Fig. S1 F).
To assess the spatial and temporal characteristics of neu-
ronal DCV release in a quantitative way, we used an optical 
probe to visualize single DCV release events in hippocampal 
neurons. We found that DCVs are preferentially released from 
synaptic terminals. Release onset is faster, and the rate of re-
lease is higher at synapses compared with extrasynaptic sites. 
To unravel underlying molecular mechanisms, we investigated 
the role of the Munc13 family members Munc13-1 and -2, SV 
Figure 1. Optical sensor for DCV release in neurons. (A) Schematic repre-
sentation of an optical reporter for DCV release that allows visualization of 
single DCV fusion events. PM, plasma membrane. (B) Confocal image of a 
neuron transfected with Semaphorin-3a–pHluorin (cargo-pH) and stained 
for endogenous DCV cargo chromogranin A (ChromoA) showing complete 
overlap (arrowheads). (C) Image series showing a cargo-pHluorin release 
event (arrows) and the NH4+ response to reveal all vesicles in the neurite 
(arrowheads). (D) Normalized frequency distribution of F for DCV release 
events measured with Semaphorin-3a–pHluorin and F upon NH4+ perfu-
sion (NH4+: 395 puncta, 7 cells; release: 293 puncta, 30 cells; median 
F release = 5.4 a.u.; median F NH4+ = 6.0 a.u.). (E) Frequency dis-
tribution of DCV release events measured with Semaphorin-3a–pHluorin 
(570 release events in 53 cells; blue bars, 16 bursts of 50 APs at 50 Hz). 
(F) DCV release events during 60 s before stimulation, during stimulation, 
and during 70 s after stimulation (before: 1 ± 0.6; during: 16 ± 3.4; after: 
5 ± 1.3 vesicles/cell; n = 21 cells, n = 3). **, P < 0.01. Data are plotted 
as means with SEM. Bars, 2 µm.
885Munc13 controls neuronal DCV release • van de Bospoort et al.
synapses in five cells). Hence, in hippocampal neurons most 
synapses do not contain DCVs.
As DCVs are smaller than our resolution limit, indi-
vidual DCV puncta may contain multiple DCVs. To assess 
this, we compared fluorescence intensity of individual puncta 
We first tested whether DCVs accumulate at synapses. 
In fixed neurons, 18.7 ± 3.1% of synapsin-labeled terminals 
overlapped with DCV-pHluorin puncta (n = 616 synapses 
measured in four cells). Similar results were obtained for the 
endogenous cargo Secretogranin II (19.9 ± 3.7%, n = 493 
Figure 2. DCV release is enriched and more efficient at synapses although DCVs do not accumulate at synaptic regions. (A) Example of a synaptic (filled 
arrowheads) and an extrasynaptic release event (open arrowheads). Synapsin-mCherry is shown in red, and release events are shown in green. Bar, 1 µm. 
(B) Cartoon showing a synaptic (left green dot) and extrasynaptic (right green dot) release event. (C) Overlay of frequency distribution of F upon NH4+ 
application for synaptic (syn) DCV puncta (synaptic 589 puncta) and extrasynaptic (e-syn) DCV puncta (extrasynaptic 612 puncta). (D) Individual frequency 
distributions of F upon NH4+ application. (E) Electron micrographs of synaptic terminals that harbor DCVs. Arrowheads point to DCVs. Bars, 100 nm. 
(F) Diameter of DCVs in electron micrographs (mean diameter: 68.9 ± 1.0 nm, 146 DCVs in 7 cells). (G) Number of DCVs per synaptic profile (102 synapses 
in 7 cells). Inset, ±22% of synaptic DCVs is docked to the plasma membrane (undocked, 113; docked, 33; total, 146). (H) Percentage of synaptic and 
extrasynaptic DCV release events measured with Semaphorin-3a–pHluorin (235 synaptic release events, 131 extrasynaptic release events; n = 34 cells, 
n = 3; *, P < 0.05). (I) Cumulative number of release events per cell for synaptic and extrasynaptic events. (Synaptic release rate: 0.26 ± 0.03 vesicles/s; 
extrasynaptic: 0.13 ± 0.02 vesicles/s). Shading represents SEM. (J) Cumulative number of events during the first four bursts (blue bars 1, 2, 3, and 4 
represent 50 APs at 50 Hz) for synaptic and extrasynaptic events. (K) Example traces of synaptic (red) and extrasynaptic (black) release events. Arrows 
mark start of the stimulation. Data are plotted as means with SEM.
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Munc13-1 is highly enriched in presynaptic terminals 
(Kalla et al., 2006) and could thus influence the localization 
of DCV release. We first excluded that deletion of Munc13-1 
affected DCV localization in the synapse using electron mi-
croscopy (Fig. S3, C and D). Next, using synapsin-mCherry as 
a synaptic marker, we found that Munc13-1/2 deletion did not 
change the localization of DCVs before release (Fig. S2 C and 
Fig. 3 D) but strongly affected the ratio of synaptic versus ex-
trasynaptic release (Fig. 3 E) by reducing the number of syn-
aptic release events (Fig. 3 F). This suggests that Munc13-1 
specifically promotes synaptic DCV release. Consistent with 
this observation, Munc13-1/2 deletion affected synaptic DCV 
release rates much more than extrasynaptic release (WT syn-
aptic: 0.49 ± 0.09 vesicles/s; M13DKO synaptic: 0.17 ± 0.1 
vesicles/s; P < 0.05; WT extrasynaptic: 0.24 ± 0.08 vesicles/s; 
M13DKO extrasynaptic 0.16 ± 0.13 vesicles/s; Fig. 3, G and H). 
Hence, Munc13 deletion does not alter DCV localization or 
mobility at steady state. It does, however, specifically affect 
the amount and rate of synaptic DCV release.
M13OE increases the number  
of extrasynaptic DCV release events
M13OE in bovine chromaffin cells enhances DCV release 
(Ashery et al., 2000). To test whether similar principles apply 
for DCV release in neurons, we tested the effect of M13OE in 
WT hippocampal neurons. M13OE resulted in a more than 
fourfold increase in protein levels compared with endogenous 
levels (Fig. 4 A). Endogenous Munc13-1 showed a clear punc-
tate localization, which overlapped with synapsin-mCherry. In 
contrast, overexpressed Munc13-1 was not restricted to syn-
apses but distributed homogenously throughout the neurites 
(Fig. 4 B). Similar ectopic expression of Munc13-1 has been 
observed before (Deng et al., 2011).
M13OE did not change the total number or localization 
of DCVs (Fig. S2, B and C; and Fig. 4 C) but significantly in-
creased DCV release events compared with WT (WT: 10.1 ± 
1.8, n = 36; M13OE: 18.4 ± 3.2, n = 32; P < 0.05; Fig. 4 D). 
Release started earlier in M13OE neurons (Fig. 4, E and F), 
although this effect was rather subtle when measured regard-
less of the spatial localization of the events. However, as in 
M13DKO neurons, the preference for DCV release at synap-
tic sites was lost in M13OE neurons (Fig. 4 G). In contrast to 
Munc13 deletion, this was now caused by a specific increase 
in DCV release events at extrasynaptic sites (Fig. 4 H) with 
significantly increased vesicle release rates at these sites (WT 
extrasynaptic: 0.24 ± 0.04 vesicles/s; M13OE extrasynaptic: 
0.36 ± 0.01 vesicles/s; P < 0.05; Fig. 4 I). In M13OE neurons, 
extrasynaptic release events occurred already during the first 
four stimuli. During this time window, WT neurons did not 
show release (Fig. 4 J). Munc13 overexpression hardly, if at all, 
affected synaptic release events (Fig. 4, K and L). Together, this 
shows that overexpression of Munc13-1 is sufficient to produce 
efficient DCV release at extrasynaptic sites.
A model for DCV release in neurons
The present study characterized mechanisms that control syn-
aptic DCV release in hippocampal neurons. We found that 
upon NH4+ application at synapses and extrasynaptic regions. 
DCV-pHluorin puncta showed a similar intensity distribution 
at synapses as outside synapses with a major population at 
6 a.u. (synaptic: median 6.0, mean 7.4 ± 0.8, n = 589 puncta; 
extrasynaptic: median 5.7, mean 7.0 ± 0.8, n = 612 puncta; 
n = 8 cells; P > 0.05; Fig. 2, C and D). Thus, the majority 
of single puncta are indeed single DCVs (compare Fig. 1 D 
with Fig. 2, C and D), whereas some puncta comprise multiple 
DCVs (between one and four with 6 a.u. representing a single 
DCV; Fig. 1 D). These DCV clusters are present at extrasyn-
aptic as well as synaptic sites with no specific enrichment in 
synapses. Electron micrographs corroborated these findings 
and revealed both single DCVs and DCV clusters outside syn-
aptic areas (Fig. S2 D). On average 1.4 DCVs were present per 
synapse section (mean DCV diameter: 68.9 ± 1.0 nm; Fig. 2, 
E and F), and almost half of the sections did not contain 
DCVs (Fig. 2 G). In sections with DCVs, most DCVs were 
randomly distributed in the terminal, whereas ±22% were 
physically attached (docked) to the active zone (Fig. 2 G, 
inset). Together, these data show that most synapsin-labeled 
terminals do not contain DCVs and that DCV clusters are not 
enriched in terminals at rest.
Yet, the majority of DCV release events occurred at syn-
apsin-positive regions (synaptic: 66%, 315 events; extrasynaptic: 
34%, 165 events; n = 34 cells; n = 3; Fig. 2 H), and DCV 
release rates were much slower at extrasynaptic sites than at 
synapses (synaptic: 12.6 ± 0.3 vesicles/s; extrasynaptic: 7.8 ± 
0.2 vesicles/s; P < 0.05; Fig. 2 I). In line with this observation, 
synaptic DCV release required less intense stimulation com-
pared with extrasynaptic release: already after the first 50 APs, 
DCVs were released at synapses, whereas extrasynaptic release 
started only after three bursts of 50 APs (Fig. 2, I and J). Apart 
from the kinetic difference, no differences were observed in 
the size and shape of the individual release events (Fig. 2 K). 
Hence, DCV release probability at synapses is higher than out-
side these regions.
Deletion of Munc13-1 reduces and delays 
synaptic DCV release
To gain insight into the molecular priming mechanisms of neu-
ronal DCV release, we tested the role of the SV priming proteins 
of the Munc13 family in the munc13-1/2–null mutant (Munc13 
double knockout [KO; M13DKO]) mice. In M13DKO neurons, 
the number of DCVs per cell was not changed (Fig. S2 A), but 
DCV release was reduced by >60% compared with wild type 
(WT: 11.8 ± 2.3, n = 41 cells; M13DKO: 4.7 ± 1.0, n = 23 
cells; P < 0.01; Fig. 3 A). In addition, DCV release rates 
were slower (WT: 0.73 ± 0.12 vesicles/s; M13DKO: 0.32 ± 
0.1 vesicles/s; P < 0.05; Fig. 3 B), and release required more 
prolonged stimulation as M13DKO neurons released DCVs 
only after the third burst of 50 APs (Fig. 3, B and C). Hence, 
deletion of Munc13-1/2 strongly reduces the number and rate 
of DCV release events. In contrast to SV release, however, it 
does not totally abolish DCV release. Munc13-1 single null 
mutant neurons showed a similar strong reduction of DCV 
release, indicating that Munc13-1 is the dominant isoform 
supporting DCV release (Fig. S3).
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±20% of the DCV release events to occur at synaptic sites. Yet, 
we found that >65% of all events did. Release at synapses 
started earlier upon stimulation and reached higher release rates 
than extrasynaptic release. As we did not find evidence for syn-
aptic accumulation of DCVs before release, we conclude that 
DCV release probability at synaptic terminals is higher than at 
extrasynaptic sites. As most DCVs in mammalian neurons are 
mobile (Silverman et al., 2005; Ramamoorthy et al., 2011), on 
average, only one in five synapses harbors stationary DCVs 
(Fig. 2; de Wit et al., 2006; Matsuda et al., 2009), which are of-
ten not predocked (Verhage et al., 1991; Silverman et al., 2005; 
de Wit et al., 2006, 2009b; Matsuda et al., 2009), these findings 
suggest that DCVs are recruited to synapses during activity and, 
consequently, dock and fuse from an undocked, mobile state 
during stimulation.
We found that loss of Munc13-1/2 strongly reduced 
DCV release and that Munc13-1 is the dominant isoform sup-
porting DCV release. Hence, Munc13 emerges as a general 
priming factor for regulated secretion of different types of 
secretory vesicles (SVs and DCVs). However, almost 40% of 
the fusion events remained in M13DKO neurons, whereas SV 
although DCVs are not enriched in synaptic terminals, they 
preferentially fuse at synapses. Release at extrasynaptic sites 
only occurs upon more prolonged stimulation compared with 
synaptic DCV release. We provide evidence that the synaptic 
priming proteins Munc13-1 and Munc13-2 are, unlike in SV 
secretion (Varoqueaux et al., 2002), not essential for DCV 
release but primarily control the localization and efficiency 
of DCV release: In their absence, synaptic preference of DCV 
fusion is lost, and remaining release events require stimula-
tion intensities similar to extrasynaptic release events in WT 
neurons, whereas overexpression promotes extrasynaptic re-
lease events that do not require prolonged stimulation.
Colocalization with synapsin-mCherry and post hoc con-
firmation using immune detection indicated that only a small 
proportion (±20%) of the 100–150 DCV (clusters) present in 
WT, M13DKO, and M13OE neurons localizes to synaptic sites. 
Random sections of presynaptic profiles contained on average 
1.4 DCVs with few postsynaptic DCVs, and almost half of the 
profiles were devoid of DCVs. Hence, our data suggest that 
there is no strong accumulation of DCVs in hippocampal syn-
apses. Based on the observed DCV distribution, we expected 
Figure 3. Munc13 specifically reduces DCV release at synapses. (A) Mean number of DCV release events per cell for WT and Munc13-1/2 DKO 
(M13DKO) neurons measured with Semaphorin-3a–pHluorin (WT: 482 events, n = 41 cells; M13DKO: 108 events, n = 23 cells; n = 4; **, P < 0.01). 
(B) Cumulative number of release events per cell. (C) Cumulative (cum.) number of release events during the first four bursts of 50 APs at 50 Hz. (D) Percent-
age of synaptically localized DCVs that remain synaptic during 10-s acquisition (WT: 221 vesicles, n = 6 cells; M13DKO: 146 vesicles, n = 5 cells; n = 2). 
(E) Percentage of synaptic and extrasynaptic DCV release events in WT and M13DKO neurons (WT: 21 cells; M13DKO: 23 cells; n = 4; *, P < 0.05; 
**, P < 0.01). (F) Total numbers of synaptic and extrasynaptic events show a specific loss of synaptic events (total events: WT, 255; M13DKO, 151). Red 
dotted line shows difference in bar heights. (G) Cumulative number of synaptic DCV release events. (H) Cumulative number of extrasynaptic DCV release 
events. Shading represents SEM. Data are plotted as means with SEM.
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DCV fusion in WT neurons. So, DCV fusion appears to lose 
its synaptic advantage upon Munc13 loss. This is consistent 
with the highly localized distribution of Munc13-1/2 to active 
zones (Kalla et al., 2006).
Conversely, M13OE leads to many more DCV fusion 
events at extrasynaptic sites, which also required less intense 
fusion is abolished completely in such neurons (Varoqueaux et al., 
2002). In fact, our data show that impaired release efficiency is 
the main effect of Munc13-1/2 loss: in their absence, the first 
fusion events occur only after three to four episodes of 50 APs 
at 50 Hz. This is the same type of drastic stimulation, which 
may be very rare in vivo, required to trigger extrasynaptic 
Figure 4. M13OE increases DCV release at extrasynaptic sites. (A) Normalized Munc13-1 intensity in WT neurons compared with neurons overexpressing 
Munc13-1 (M13OE, n = 3; **, P < 0.001). (B) Confocal image of a WT neuron with endogenous Munc13-1 and a WT neuron overexpressing Munc13-1 
(arrowheads show synaptic localization of Munc13). Bars, 2 µm. (C) Percentage of synaptically localized DCVs that stay synaptic for 10 s (WT: 199 
vesicles, n = 7 cells; M13OE: 170 vesicles, n = 7 cells). (D) Mean number of DCV release events per cell (WT: 361 events in 36 cells; M13OE: 588 
events in 32 cells; n = 3; *, P < 0.05). (E) Cumulative (cum.) DCV release events per cell. (F) Cumulative number of release events during the first four bursts 
of 50 APs at 50 Hz. (G) Percentage of synaptic and extrasynaptic DCV release events (**, P < 0.01; *, P < 0.05). (H) Total numbers of synaptic and 
extrasynaptic DCV release events. Loss of synaptic preference is caused by an increase of extrasynaptic release events in M13OE. Red dotted line shows 
difference in bar heights. (I) Cumulative extrasynaptic DCV release events. (J) Cumulative number of events during the first four bursts at extrasynaptic sites. 
(K) Cumulative synaptic DCV release events. (L) Cumulative number of events during the first four bursts at synapses. Shading represents SEM. Data are 
plotted as means with SEM.
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0.5-s interval. All imaging experiments were performed at RT (21–24°C) in 
the presence of 50 µM (2R)-amino-5-phosphonovaleric acid (Tocris Biosci-
ence) and 10 µM 6,7-dinitroquinoxaline-2,3-dione (Tocris Bioscience) to 
block glutamatergic transmission. The imaging protocol consisted of a 30-s 
time lapse, applying NH4+ Tyrode’s solution after 10 s for 10 s. Then, a 
5-min recovery period was performed, in which spontaneous release was 
assessed during the last 60 s of this period. After this, a 100-s time lapse 
with electrical field stimulation was recorded. Field stimulation started after 
3 s and lasted 24 s. Spontaneous events after the stimulation were counted 
during the last 70 s. Furthermore, ECFP and synapsin-mCherry images 
were acquired before and after the recording for further analysis. Neurons 
in which ECFP or synapsin-mCherry masks before and after stimulation 
shifted >1 pixel (0.165 µm) were discarded from the analysis.
Image analysis
Stacks from time-lapse recordings acquired with 0.5-s intervals were used 
to analyze DCV release. A 4 × 4–pixel region (0.6 × 0.6 µm) of interest 
was centered on each event, and the mean intensity of the fluorescence 
was measured with MetaMorph software. Fluorescent traces were ex-
pressed as the fluorescence change (F) compared with the initial fluores-
cence (F0), obtained by averaging the first four frames of the time-lapse 
video. Onset of exocytosis was defined as the first frame with an increase 
of fluorescence of two SDs above F0. DCV release rates were measured 
from linear fits of the cumulative plots. Colocalization with synapsin was 
measured by overlaying both images in MetaMorph. A cargo-pHluorin 
release event or punctum was scored as synaptic when the fluorescence 
center of such a release event/punctum was within 200 nm (±1 pixel, the 
approximate minimal point spread function of our system) of the synapsin-
mCherry fluorescence centroid. Extrasynaptic events were all events that 
did not meet this criterion. We only measured release events from neu-
rites and excluded somatic release events. Somatic release events cannot 
be reliably measured using wide-field fluorescence microcopy because 
of the bright fluorescence from vesicles in/near the Golgi apparatus in 
which the intraluminal pH is not yet acidic. The total number of vesi-
cles was automatically analyzed from the NH4+ application time lapse 
using SynD software (Schmitz et al., 2011). In Fig. 3 D and Fig. 4 C, 
the localization and dynamics of DCVs were determined by analyzing 
cargo-pHluorin–labeled vesicles during NH4+ application. Per neuron, 
four 50-µm regions containing synapses were selected for line scan mea-
surements. DCV fluorescence peaks one SD above mean were scored for 
overlap with synapsin-mCherry fluorescence peaks at the first frame of a 
10-s time window. During these 10 s, even the slowest moving DCVs in 
our system (0.29 µm/s; de Wit et al., 2006) would have traveled ±3 µm 
(or >18 pixels). Stable DCVs are therefore defined as DCVs that do not 
leave the synaptic area in 10 s.
Immunocytochemistry
After imaging, cells were fixed in 4% formaldehyde (Electron Microscopy 
Sciences) in PBS, pH 7.4, for 20 min at RT. Cells were washed in PBS and 
first permeabilized for 5 min in PBS containing 0.5% Triton X-100 (Sigma-
Aldrich) and then incubated for 30 min with PBS (Gibco) containing 2% 
normal goat serum and 0.1% Triton X-100. Incubations with primary and 
secondary antibodies were performed for 1 h at RT. Primary antibodies 
used were polyclonal MAP2 (Abcam), monoclonal VAMP2 (Synaptic Sys-
tems), polyclonal Munc13 (Synaptic Systems), polyclonal chromogranin A, 
and polyclonal secretogranin II (gifts from P. Rosa, Institute of Neurosci-
ence, Milan, Italy). Alexa Fluor–conjugated secondary antibodies were 
obtained from Invitrogen. Coverslips were mounted in Mowiol and exam-
ined on a confocal laser-scanning microscope (LSM 510; Carl Zeiss) with 
a 40× objective, NA 1.3.
Electron microscopy
Neurons were fixed at DIV14–16 for 1–2 h at RT with 0.1 M cacodyl-
ate buffer/0.25 mM CaCl2/0.5 mM MgCl2, pH 7.4, and processed as 
previously described (Wierda et al., 2007; Meijer et al., 2012). In brief, 
cells were postfixed for 2 h at RT with 1% osmium tetroxide/1% potassium 
ferro-cyanide, washed, and stained with 1% uranyl acetate for 40 min in 
the dark. After dehydration, cells were embedded in Epon. Cells of interest 
were selected using the light microscope and mounted on prepolymerized 
Epon blocks for thin sectioning. Ultrathin sections (90 nm) were cut paral-
lel to the cell monolayer, collected on single-slot, Formvar-coated copper 
grids, and stained in uranyl acetate and lead citrate. Synapses with a rec-
ognizable pre- and postsynaptic density were randomly selected using an 
electron microscope (1010; JEOL) and imaged at 100.000× using analy-
sis software (Soft Imaging System). The observer was blinded for the 
stimulation. Upon overexpression, nonsynaptic DCV fusion 
events appeared to gain synaptic-like properties, and over-
expression of Munc13-1 appears to be sufficient to specify 
extrasynaptic DCV release sites. Munc13 interacts with the 
t-SNARE protein syntaxin and the Sec1/Munc18 protein 
Munc18 (Richmond et al., 2001; Ma et al., 2011). These pro-
teins serve as essential and minimal components for membrane 
fusion in many systems (Verhage et al., 2000; Rizo and Südhof, 
2002; Toonen and Verhage, 2007) and are not exclusively 
present at synapses (Galli et al., 1995). Munc13 could organize/
activate extrasynaptic t-SNARE–Munc18 complexes to in-
crease DCV release probability at these sites.
Materials and methods
Plasmids
Semaphorin-3a–pHluorin was generated by replacing EGFP in Sema-
phorin-3a–EGFP (De Wit et al., 2005) with the superecliptic pHluorin 
(SpH) coding sequence (de Wit et al., 2009b). NPY-SpH was generated 
by replacing Venus (Nagai et al., 2002) with SpH (de Wit et al., 2009b). 
Synapsin-mCherry was a gift from A. Jeromin (Allen Brain Institute, 
Seattle, WA).
Laboratory animals
M13DKO mice have been described before (Varoqueaux et al., 2002). 
Munc13-1 KO mice were generated by replacing four exons, represent-
ing bp 2,587–2,964 of rat Munc13-1 with a neomycin resistance gene 
(Augustin et al., 1999). To generate Munc13-2 KO mice, a 6-kb genomic 
fragment containing multiple exons of the Munc13-2 gene that are shared 
by the two Munc13-2 splice variants (bp 2,907–3,904 of brain-specific 
Munc13-2 cDNA [available under GenBank accession no. U24071]; bp 
1,439–2,436 of ubiquitous Munc13-2 cDNA [GenBank accession no. 
AF159706]) was replaced by a neomycin resistance cassette. Embryonic 
day 18 embryos were obtained by caesarean section of pregnant females 
from timed matings of Munc13-2 homozygous and Munc13-1 heterozy-
gous mice. M13DKO embryos are stillborn, and M13DKO neurons in cul-
ture (day in vitro [DIV] 14) show neither evoked nor spontaneous release 
events yet form normal numbers of synapses with typical ultrastructural 
features. Animals were housed and bred according to institutional, Dutch, 
and U.S. governmental guidelines.
Primary neuronal cell culture and transfection
Dissociated hippocampal neurons were prepared from embryonic day 18 
mice as previously described (de Wit et al., 2009b). Hippocampi were 
dissected in HBSS (Sigma-Aldrich) and digested with 0.25% trypsin 
(Invitrogen) for 20 min at 37°C. Hippocampi were washed and triturated 
with fire-polished Pasteur pipettes, counted, and plated in Neurobasal 
medium (Invitrogen) supplemented with 2% B-27 (Invitrogen), 1.8% Hepes, 
1% GlutaMAX (Invitrogen), and 1% penicillin-streptomycin (Invitrogen). 
High-density cultures (25,000 neurons/well) were plated on pregrown 
cultures of rat glia cells (37,500 cells/well) on 18-mm glass coverslips in 
12-well plates. At DIV10, neuronal cultures were transfected with calcium 
phosphate with DCV-pHluorin together with synapsin-mCherry (to identify 
synapses) and ECFP (as a neuronal morphology marker). Neurons were 
imaged at DIV14–DIV15.
Imaging
Coverslips were placed in an imaging chamber and perfused with Tyrode’s 
solution (2 mM CaCl2, 2.5 mM KCl, 119 mM NaCl, 2 mM MgCl2, 
20 mM glucose, and 25 mM Hepes, pH 7.4) and imaged on a micros-
cope (Axio Observer.Z1; Carl Zeiss) equipped with a camera (CoolSNAP 
HQ; Photometrics) and an illumination unit (Polychrome IV; TILL Photonics). 
Images were acquired at 2 Hz with MetaMorph 6.2 software (Universal 
Imaging) using a 40× objective, NA 1.3. Intracellular pH was neutralized 
with normal Tyrode’s solution containing 50 mM NH4Cl, which replaced 
NaCl on an equimolar basis in the solution. A barrel pipette was used 
to apply NH4+ solution to the cells. Electrical field stimulation by parallel 
platinum electrodes was applied by a Master-8 system (A.M.P.I.) and a 
stimulus generator (A385RC; World Precision Instruments) delivering 30-mA, 
1-ms pulses. The stimulus used was 16 trains of 50 APs at 50 Hz with 
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Statistics
Throughout the paper, Student’s t tests for unpaired data were used unless 
otherwise specified. If F tests showed significantly different SDs, Student’s 
t tests were Welch corrected. Mann–Whitney tests were used to compare 
groups when one or both did not pass the normality test. To test more than 
two groups, Kruskal–Wallis one-way analysis of variance with post hoc 
Dunn’s multiple comparisons test was used. Kolmogorov–Smirnov test was 
used to test whether distributions were normally distributed and for testing 
frequency distributions. Data are plotted as means with SEM.
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